Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.460
-0.360 (-12.77%)
At close: Jan 28, 2026, 4:00 PM EST
2.490
+0.030 (1.22%)
After-hours: Jan 28, 2026, 4:53 PM EST
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $19.66 million as of January 28, 2026. Its market cap has decreased by -32.88% in one year.
Market Cap
19.66M
Enterprise Value
16.11M
1-Year Change
-32.88%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $19.66M, a decrease of -95.20%. That is a compound annual growth rate of -21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 22.53M | 149.56% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 20.95M |
| BioAtla | 20.71M |
| CASI Pharmaceuticals | 20.24M |
| Allarity Therapeutics | 20.14M |
| Liminatus Pharma | 19.83M |
| OSR Holdings | 19.63M |
| Pasithea Therapeutics | 19.43M |
| Lexaria Bioscience | 19.41M |